Skopos Labs, Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Skopos Labs, Inc.
- $813 Million
- Q3 2025
A detailed history of Skopos Labs, Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 11,084 shares of EYPT stock, worth $131,345. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,084
Previous 11,416
2.91%
Holding current value
$131,345
Previous $157,000
2.55%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
68MCall Options Held
421KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.19MShares$73.4 Million2.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$49.4 Million0.02% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...